Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide) injection.

BENGALURU, July 7 (Reuters) - Indian drugmaker Cipla , opens new tab said on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol due to a "container defect".

Cipla subsidiary InvaGen issued a voluntary recall of one lot of the oral anti-seizure drug vigabatrin due to problems with seal integrity in its packaging. The recalled lot of the medication ...

Cipla US has recalled six batches of the 90 mcg albuterol sulfate inhalation aerosols that expire in November 2023. Skip to Article. Set weather. Back To Main Menu Close. Quick Look- ...

Cipla, which is one of the world’s largest generic drug manufacturers, was recently cited by inspectors from the U.S. Food and Drug Administration for a litany of violations at a plant in India.

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain following ocular surgery across 11 countries such as India, South ...